Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

Prolactin may be important for skin growth and immune function.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Finasteride caused enlarged breast tissue in a 62-year-old man.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.